Biohaven’s Opakalim Shows Strong Seizure Control and Superior Tolerability in Epilepsy Clinical Trials
Biohaven Reports Promising New Clinical Data for Opakalim in...
Sign in to continue:
Biohaven Reports Promising New Clinical Data for Opakalim in...
Willis Lease Finance Corporation Announces Results of 2026 A...
Eightco Holdings Inc. - Significant Corporate Update ...
NIL Disclaimer: This summary is provided for informational p...
Six Flags Entertainment Corporation (NYSE: FUN) – 2026 Annua...
Teleflex Incorporated Enters New Credit Agreement: Key Detai...
Silvaco Group, Inc. Files Form 8-K Announcing Change in Inde...
LivePerson Q1 2026 Financial Report: In-depth Investor Analy...
PennantPark Floating Rate Capital Ltd. Announces \$100 Milli...
Maui Land & Pineapple Company, Inc. Reports Results of 2026 ...